Pfizer Hits a New 52-Week High. Here's Why It's Not Too Late to Buy the Stock
Key PointsPfizer's recently launched and acquired products have been generating impressive growth.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.